Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

Oncology Reports- Greece

doi 10.3892/or.2014.3197

Full Text

Abstract

Available in

Categories

Cancer Research

Date

May 16, 2014

Authors

SHINSUKE HASHIDA

SHINICHI TOYOOKA

MASASHI FURUKAWA

HIROMASA YAMAMOTO

KAZUNORI TSUKUDA

KOICHI HAGIWARA

SHINICHIRO MIYOSHI

Publisher

Spandidos Publications

Related search

P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance

Journal of Thoracic Oncology

Respiratory Medicine

English

The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

Green Medical Journal

English

In Silico Insight Into EGFR Treatment in Patients With Lung Carcinoma and T790M Mutations

Experimental and Therapeutic Medicine

Cancer Research

English

MA15.10 Loss of T790M Mutation Is Associated With Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-80 Retrospective Analysis of the Impact of EGFR T790M Mutation Detection by Re-Biopsy in Patients With NSCLC Harboring EGFR Mutations.

Journal of Thoracic Oncology

Respiratory Medicine

English

Tissue Is the Issue for Diagnosis of EGFR T790M Mutation

Journal of Thoracic Oncology

Respiratory Medicine

English

MA27.07 Lung Adenocarcinoma Harboring BRAF G469V Mutation Is Uniquely Sensitive to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology

Respiratory Medicine

English

Relationship Between EGFR Mutation and Computed Tomography Characteristics of the Lung in Patients With Lung Adenocarcinoma

Thoracic Cancer

Respiratory Medicine

English

P2.13-12 the deNovo T790M Mutation Recovered by ddPCR Is Associated With a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma.

Journal of Thoracic Oncology

Respiratory Medicine

English